TWiV 85: Hepatitis C virus with Professor Michael Gale

June 6, 2010

Hosts: Vincent Racaniello and Michael Gale

Vincent and Michael Gale discuss the origin, pathogenesis, prevention, of hepatitis C virus, and how it evades innate immune responses.

This episode is sponsored by Data Robotics Inc.

Click the arrow above to play, or right-click to download TWiV #85 (40 MB .mp3, 56 minutes)

Subscribe (free): iTunesRSSemail

Links for this episode:

  • The Gale Laboratory at the University of Washington
  • Incredible view from the Gale laboratory (jpg)
  • Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses (review)
  • New potent HCV inhibitor
  • HCV virion and genome structures at ViralZone
  • Episode transcript (pdf)

Send your virology questions and comments to twiv@microbe.tv.

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 85: Hepatitis C virus with Professor Michael Gale

  1. Nicole Lascurain Jun 19, 2015

    Hi,

    First off, I came across your site and wanted to say thanks for providing a great resource on disease for the community.

    I thought you might find this interactive infographic interesting, detailing the effects of Hepatitis C on the body. I know our readers have given us great feedback, and thought yours might get a kick out of it too! http://www.healthline.com/health/hepatitis-c/effects-on-the-body

    Naturally, I’d be delighted if you share this embeddable graphic on http://www.twiv.tv/2010/06/06/twiv-85-hepatitis-c-virus-with-professor-michael-gale/ , and/or with your followerson social. Either way, keep up the great work !

    All the best,

    Nicole

    Nicole Lascurain • Assistant Marketing Manager

    p: 415-281-3130 | e: nicole.lascurain@healthline.com

    Healthline • The Power of Intelligent Health

    660 Third Street, San Francisco, CA 94107

    http://www.healthline.com | @Healthline | @HealthlineCorp

    Healthline.com is a trusted health information resource for over 30 million people. All content undergoes a rigorous editorial process. Learn more about Healthline at: http://www.healthline.com/health/about-healthline